Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease
Kobro-Flatmoen, Asgeir ; Hormann, Thea Meier and Gouras, Gunnar LU
(2023)
In Journal of Alzheimer's disease : JAD
95(2).
p.719-733
- Abstract
BACKGROUND: Amyloid-β (Aβ) is a normal product of neuronal activity, including that of the aggregation-prone Aβ42 variant that is thought to cause Alzheimer's disease (AD). Much knowledge about AD comes from studies of transgenic rodents expressing mutated human amyloid-β protein precursor (AβPP) to increase Aβ production or the Aβ42/40 ratio. Yet, little is known about the normal expression of Aβ42 in rodent brains.
OBJECTIVE: To characterize the brain-wide expression of Aβ42 throughout the life span of outbred Wistar rats, and to relate these findings to brains of human subjects without neurological disease.
METHODS: Aβ42 immunolabeling of 12 Wistar rat brains (3-18 months of age) and brain sections from six human subjects... (More)
BACKGROUND: Amyloid-β (Aβ) is a normal product of neuronal activity, including that of the aggregation-prone Aβ42 variant that is thought to cause Alzheimer's disease (AD). Much knowledge about AD comes from studies of transgenic rodents expressing mutated human amyloid-β protein precursor (AβPP) to increase Aβ production or the Aβ42/40 ratio. Yet, little is known about the normal expression of Aβ42 in rodent brains.
OBJECTIVE: To characterize the brain-wide expression of Aβ42 throughout the life span of outbred Wistar rats, and to relate these findings to brains of human subjects without neurological disease.
METHODS: Aβ42 immunolabeling of 12 Wistar rat brains (3-18 months of age) and brain sections from six human subjects aged 20-88 years.
RESULTS: In healthy Wistar rats, we find intracellular Aβ42 (iAβ42) in neurons throughout the brain at all ages, but levels vary greatly between brain regions. The highest levels are in neurons of entorhinal cortex layer II, alongside hippocampal neurons at the CA1/subiculum border. Concerning entorhinal cortex layer II, we find similarly high levels of iAβ42 in the human subjects.
CONCLUSION: Expression of iAβ42 in healthy Wistar rats predominates in the same structures where iAβ accumulates and Aβ plaques initially form in the much used, Wistar based McGill-R-Thy1-APP rat model for AD. The difference between wild-type Wistar rats and these AD model rats, with respect to Aβ42, is therefore quantitative rather that qualitative. This, taken together with our human results, indicate that the McGill rat model in fact models the underlying wild-type neuronal population-specific vulnerability to Aβ42 accumulation.
(Less)
- author
- Kobro-Flatmoen, Asgeir
; Hormann, Thea Meier
and Gouras, Gunnar
LU
- organization
- publishing date
- 2023-08-10
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Alzheimer's disease, animal model, disease onset, entorhinal cortex
- in
- Journal of Alzheimer's disease : JAD
- volume
- 95
- issue
- 2
- pages
- 15 pages
- publisher
- IOS Press
- external identifiers
-
- scopus:85171601441
- pmid:37574734
- ISSN
- 1387-2877
- DOI
- 10.3233/JAD-230349
- language
- English
- LU publication?
- yes
- id
- 38751127-5ff6-4d1f-9f95-de33805231ba
- date added to LUP
- 2023-08-27 22:46:38
- date last changed
- 2024-04-20 02:41:17
@article{38751127-5ff6-4d1f-9f95-de33805231ba,
abstract = {{<p>BACKGROUND: Amyloid-β (Aβ) is a normal product of neuronal activity, including that of the aggregation-prone Aβ42 variant that is thought to cause Alzheimer's disease (AD). Much knowledge about AD comes from studies of transgenic rodents expressing mutated human amyloid-β protein precursor (AβPP) to increase Aβ production or the Aβ42/40 ratio. Yet, little is known about the normal expression of Aβ42 in rodent brains.</p><p>OBJECTIVE: To characterize the brain-wide expression of Aβ42 throughout the life span of outbred Wistar rats, and to relate these findings to brains of human subjects without neurological disease.</p><p>METHODS: Aβ42 immunolabeling of 12 Wistar rat brains (3-18 months of age) and brain sections from six human subjects aged 20-88 years.</p><p>RESULTS: In healthy Wistar rats, we find intracellular Aβ42 (iAβ42) in neurons throughout the brain at all ages, but levels vary greatly between brain regions. The highest levels are in neurons of entorhinal cortex layer II, alongside hippocampal neurons at the CA1/subiculum border. Concerning entorhinal cortex layer II, we find similarly high levels of iAβ42 in the human subjects.</p><p>CONCLUSION: Expression of iAβ42 in healthy Wistar rats predominates in the same structures where iAβ accumulates and Aβ plaques initially form in the much used, Wistar based McGill-R-Thy1-APP rat model for AD. The difference between wild-type Wistar rats and these AD model rats, with respect to Aβ42, is therefore quantitative rather that qualitative. This, taken together with our human results, indicate that the McGill rat model in fact models the underlying wild-type neuronal population-specific vulnerability to Aβ42 accumulation.</p>}},
author = {{Kobro-Flatmoen, Asgeir and Hormann, Thea Meier and Gouras, Gunnar}},
issn = {{1387-2877}},
keywords = {{Alzheimer's disease; animal model; disease onset; entorhinal cortex}},
language = {{eng}},
month = {{08}},
number = {{2}},
pages = {{719--733}},
publisher = {{IOS Press}},
series = {{Journal of Alzheimer's disease : JAD}},
title = {{Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease}},
url = {{http://dx.doi.org/10.3233/JAD-230349}},
doi = {{10.3233/JAD-230349}},
volume = {{95}},
year = {{2023}},
}